MiSight Contact Lenses are the first FDA-Approved contacts lenses that are proven to slowstop the progression of Myopia while improving nearsightedness in children aged 8 to 12. While Orthokeratology (“Ortho-K”) contact lenses are effective at treating symptoms of Myopia, they have only a temporary effect. If you stop using the treatment, your eyesight may eventually return to its prior state.
MiSight Contact Lens are different. Several multi-year studies prove MiSight Contact Lenses do more than improve the symptoms of Myopia. They effectively slow the progression of Myopia when used as directed.
Myopia, or nearsightedness, is a condition that makes it easy to see things up close and difficult to see things far away. It can affect both children and adults. MiSight Contact Lenses are the first FDA-approved contact lens to treat childhood myopia in children aged 8 to 12. They are single-use contact lenses that should be worn during the day and disposed of at night.
Several clinical trials have shown the effectiveness of MiSight:
According to these and other studies, MiSight Contact Lenses effectively slow the progression of Myopia symptoms better than glasses and other types of contact lenses. MiSight is also reported to have no rebound effect, which means that as long as the contact lenses are used daily for at least 24-36 months, gains made during that time will remain even after treatment stops. In other words, your eyes will not revert to their prior shape provided that the contact lenses were used as directed.
Orthokeratology is one of the most popular treatments for Myopia management and involves wearing Ortho-K contact lenses at night. These special lenses reshape the eye while you sleep to temporarily reduce symptoms of Myopia.
Ortho-K contact lenses improve nearsightedness for up to 2 days. After 72 hours the eyes may begin to return to their previous, myopic state. In order to continue to enjoy the benefits of Ortho-K, both children and adults will have to wear the contact lenses every night for the rest of their lives.
MiSight is also FDA-approved, whereas Ortho-K and many other Myopia Control treatments remain an off-label use of the product for the slowing of the progression of Myopia.
There are a variety of other treatments for Myopia, including:
In determining the best myopia control management plan, it is important to discuss all potential options to find the plan that best fits your child.
When selecting a Myopia treatment plan for their children, parents should first consult a qualified Myopia Specialist like those at Dr. Barry Leonard & Associates. To learn more about MiSight contacts lenses for Myopia Management or to discuss other options, schedule an appointment today or call 818-891-6711.